Our Impact
2013
Generated HCV Medicines and Diagnostics Report for UNITAID
Click to see the impact
Showed HCV elimination with increased treatment and high SVR
Click to see the impact
Recommended testing and treatment of HCV using oral therapies
Click to see the impact
2014
Published the impact of HCV elimination in 15 countries
Click to see the impact
Lowered global HCV prevalence from 185 million to 80 million
Assessed the impact of HCV elimination in Egypt
Click to see the impact
2015
Published the impact of HCV elimination in 31 countries
Click to see the impact
Assessed expanding MPP’s mandate into HCV
Click to see the impact
Launched the Polaris Observatory, covering over 100 countries
Click to see the impact
2016
Launched the annual list of countries on the path to elimination
Click to see the impact
Showed the impact of national elimination with Taiwan MoH
Click to see the impact
Updated global HCV prevalence to 71 million
2017
Launched the Global Procurement Fund (GPRO)
Click to see the impact
Published a study on the impact of HCV elimination in the EU
Click to see the impact
Updated global HCV prevalence to 71 million
Click to see the impact
2018
Assessed the impact of HBV birth-dose vaccination for VIMC/Gavi
Click to see the impact
Updated global HBV prevalence to 292 million
Click to see the impact
Started shipments of quality hepatitis medicine and diagnostics
Click to see the impact
2019
Showed that HBV test and treat is more effective than SoC
Click to see the impact
Launched UHEP catalytic financing of hepatitis elimination
Click to see the impact
TBC
English 
Spanish 
French 
Russian 
Arabic